PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:36 AM ET

Sponsor Check › Person

ML
No photo found yet (own website and image search run after this page is viewed)

Michael Litwack

Named as an officer, director or promoter on SEC Form D filings · CO · Apr 22, 2009 → Jul 10, 2025

2deals (issuers)
$8.72Mreported sold
36investors
16Form D filings
2009–2025years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Michael Litwack is listed as a director on 16 SEC Form D filings by 2 issuers between Apr 2009 and Jul 2025: Armis Biopharma, Inc. (Fort Collins, CO — other health care — 2014–2025; $7.27M reported sold to 20 investors) and CHATA BIOSYSTEMS INC (Fort Collins, CO — manufacturing — 2009; $1.45M reported sold to 16 investors).

What this means 2 separate companies raised money with this person listed as director, over about 16 years. Across those companies the filings report $8.72M sold in total.

Listed alongside Alan Smith (13 shared filings), Dennis Templar (13 shared filings), Ted Ziemann (13 shared filings), Ed Neas (11 shared filings), Robert Kali (11 shared filings) and 21 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 16 public filings for Michael Litwack and found 13 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Michael Litwack has not run yet — it is joining a line of 36,832 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Michael Litwack..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

13 differences found between the filings for Michael Litwack — 3 worth asking about (compared 16 filings on Oct 24, 2026)

Worth asking · Apr 22, 2009 – Oct 30, 2009

Amount sold went down between filings — CHATA BIOSYSTEMS INC

The Apr 22, 2009 filing says $1,449,866 sold; the Oct 30, 2009 Form D says $305,823 sold — $1,144,043 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Apr 22, 2009 ↗Form D (later) · Oct 30, 2009 ↗CHATA BIOSYSTEMS INC — PartnerFacts page ↗
Sources
Worth asking · Apr 22, 2009 – Oct 30, 2009

Investor count went down between filings — CHATA BIOSYSTEMS INC

The Apr 22, 2009 filing reports 16 investors; the Oct 30, 2009 Form D reports 13 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Apr 22, 2009 ↗Form D (later) · Oct 30, 2009 ↗CHATA BIOSYSTEMS INC — PartnerFacts page ↗
Sources
Note · Jul 10, 2025

15% of the money raised went to insiders — Armis Biopharma, Inc.

The Jul 10, 2025 Form D reports $1,000,000 sold and $150,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate).

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Jul 10, 2025 ↗Armis Biopharma, Inc. — PartnerFacts page ↗
Sources
Note · Oct 30, 2009

Michael Litwack appears on 1 deal that stopped filing before reaching its target

CHATA BIOSYSTEMS INC (last filing Oct 30, 2009; $1,449,866 sold of $6,750,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

CHATA BIOSYSTEMS INC — PartnerFacts page ↗
Sources
Worth asking · Jul 11, 2008 – Feb 15, 2022

8 Form Ds were filed more than 15 days after the first sale

Form D filed 641 days after the first sale — Armis Biopharma, Inc. · Form D filed 95 days after the first sale — Armis Biopharma, Inc. · Form D filed 347 days after the first sale — Armis Biopharma, Inc. · Form D filed 66 days after the first sale — Armis Biopharma, Inc. · Form D filed 151 days after the first sale — CHATA BIOSYSTEMS INC · and 3 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Feb 15, 2022 ↗Armis Biopharma, Inc. — PartnerFacts page ↗Form D · Sep 25, 2018 ↗Form D · Feb 26, 2016 ↗
Sources
Note · Jul 11, 2008 – Jul 10, 2025

7 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Armis Biopharma, Inc. (latest filing Jul 10, 2025) · No amendment in the last 12 months on an offering that may still be open — Armis Biopharma, Inc. (latest filing Sep 15, 2022) · No amendment in the last 12 months on an offering that may still be open — Armis Biopharma, Inc. (latest filing Sep 25, 2018) · No amendment in the last 12 months on an offering that may still be open — Armis Biopharma, Inc. (latest filing Nov 17, 2017) · No amendment in the last 12 months on an offering that may still be open — Armis Biopharma, Inc. (latest filing Nov 17, 2017) · and 2 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jul 10, 2025 ↗Armis Biopharma, Inc. — PartnerFacts page ↗Form D/A · Sep 15, 2022 ↗Form D · Sep 25, 2018 ↗
Sources
Note · Feb 15, 2022 – Sep 15, 2022

Offering amount changed between filings — Armis Biopharma, Inc.

The Feb 15, 2022 filing says $8,000,000 offered; the Sep 15, 2022 Form D/A says $10,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Feb 15, 2022 ↗Form D/A (later) · Sep 15, 2022 ↗Armis Biopharma, Inc. — PartnerFacts page ↗
Sources
Note · Apr 14, 2014 – Apr 17, 2014

Offering amount changed between filings — Armis Biopharma, Inc.

The Apr 14, 2014 filing says $2,517,720 offered; the Apr 17, 2014 Form D/A says $3,197,504.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Apr 14, 2014 ↗Form D/A (later) · Apr 17, 2014 ↗Armis Biopharma, Inc. — PartnerFacts page ↗
Sources
Note · Apr 22, 2009 – Oct 30, 2009

Offering amount lowered between filings — CHATA BIOSYSTEMS INC

The Apr 22, 2009 filing says $6,750,000 offered; the Oct 30, 2009 Form D says $450,000.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D (earlier) · Apr 22, 2009 ↗Form D (later) · Oct 30, 2009 ↗CHATA BIOSYSTEMS INC — PartnerFacts page ↗
Sources
Note · Apr 22, 2009 – Oct 30, 2009

Minimum investment changed between filings — CHATA BIOSYSTEMS INC

The Apr 22, 2009 filing lists a minimum of $4,000; the Oct 30, 2009 Form D lists $0.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Apr 22, 2009 ↗Form D (later) · Oct 30, 2009 ↗CHATA BIOSYSTEMS INC — PartnerFacts page ↗
Sources
Note · Apr 14, 2014 – Feb 26, 2016

Industry group changed between filings — Armis Biopharma, Inc.

"Other" (Apr 14, 2014 to Apr 17, 2014); then "Other Health Care" (Feb 26, 2016 to Jul 10, 2025).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 14, 2014 ↗Form D · Feb 26, 2016 ↗Armis Biopharma, Inc. — PartnerFacts page ↗
Sources
Note · Apr 22, 2009 – Oct 30, 2009

Industry group changed between filings — CHATA BIOSYSTEMS INC

"Other" (Apr 22, 2009); then "Manufacturing" (Oct 30, 2009).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 22, 2009 ↗Form D · Oct 30, 2009 ↗CHATA BIOSYSTEMS INC — PartnerFacts page ↗
Sources
Note · Apr 22, 2009 – Oct 30, 2009

Reported revenue range changed between filings — CHATA BIOSYSTEMS INC

"Decline to Disclose" (Apr 22, 2009); then "$1,000,001 - $5,000,000" (Oct 30, 2009).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Apr 22, 2009 ↗Form D · Oct 30, 2009 ↗CHATA BIOSYSTEMS INC — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

4 of 9 offerings report sales commissions totalling $3,333,617; 0 report finder's fees; 1 reports proceeds to related persons totalling $150,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jul 10, 2025 D
Armis Biopharma, Inc.
File 021-551277
$0$0$150,000 (est.)None listed on this filingEDGAR ↗
Sep 15, 2022 D/A
Armis Biopharma, Inc.
File 021-433669
$0$0$0 (est.)None listed on this filingEDGAR ↗
Sep 25, 2018 D
Armis Biopharma, Inc.
File 021-322045
$490,062$0$0
Some of the proceeds may be used for general working capital purposes including the payment of salaries and other fees to those listed in Item 3.
Arete Wealth Management, LLC BrokerCheck CRD 44856 ↗EDGAR ↗
Nov 17, 2017 D/A
Armis Biopharma, Inc.
File 021-279488
$840,000 (est.)$0$0 (est.)
Some of the procedes may be used for general working capital purposes including the payment of salaries and other fees to those listed in Item 3.
CG CAPITAL MARKETS LLC BrokerCheck CRD 35513 ↗
TORREYA CAPITAL BrokerCheck CRD 16668 ↗
PRECISION SECURITIES, LLC BrokerCheck CRD 103976 ↗		EDGAR ↗
Nov 17, 2017 D
Armis Biopharma, Inc.
File 021-299074
$1,800,000 (est.)$0$0 (est.)
Some of the procedes may be used for general working capital purposes including the payment of salaries and other fees to those listed in Item 3.
APPLIED CAPITAL, LLC BrokerCheck CRD 166316 ↗
PRECISION SECURITIES, LLC BrokerCheck CRD 103976 ↗		EDGAR ↗
Jun 1, 2016 D/A
Armis Biopharma, Inc.
File 021-258951
$203,555 (est.)$0$0 (est.)
Some of the procedes may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3.
BRISTOL INVESTMENT GROUP, INC. BrokerCheck CRD 39684 ↗
via DONENFELD, ALAN PAUL (CRD 1206842 ↗)
EDGAR ↗
Feb 26, 2016 D
Armis Biopharma, Inc.
File 021-258175
$0$0$0None listed on this filingEDGAR ↗
Apr 17, 2014 D/A
Armis Biopharma, Inc.
File 021-215522
$0$0$0None listed on this filingEDGAR ↗
Oct 30, 2009 D
CHATA BIOSYSTEMS INC
File 021-43430
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Michael Litwack on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

AB
Other Health Care

Armis Biopharma, Inc.

Fort Collins, CO · Apr 14, 2014 → Jul 10, 2025 · 14 filings
  • Jul 10, 2025 · D · $1,000,000 sold of $3,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 15, 2022 · D/A · $7,270,000 sold of $10,000,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 15, 2022 · D · $5,270,000 sold of $8,000,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 25, 2018 · D · $1,832,300 sold of $10,000,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 17, 2017 · D · $125,000 sold of $30,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 17, 2017 · D/A · $2,744,835 sold of $14,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 12, 2017 · D/A · $2,744,835 sold of $14,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 9, 2017 · D/A · $0 sold of $14,000,000 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 27, 2017 · D · $0 sold of $14,000,000 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 1, 2016 · D/A · $3,255,561 sold of $5,799,999 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 10, 2016 · D · $758,299 sold of $5,799,999 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 26, 2016 · D · $1,736,920 sold of $1,736,920 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 17, 2014 · D/A · $3,197,504 sold of $3,197,504 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 14, 2014 · D · $2,517,720 sold of $2,517,720 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $7.27M from 20 investors (100% of the $3M target) as of the latest filing. Michael is listed as director on 14 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CB
Manufacturing

CHATA BIOSYSTEMS INC

Fort Collins, CO · Apr 22, 2009 → Oct 30, 2009 · 2 filings
  • Oct 30, 2009 · D · $305,823 sold of $450,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 22, 2009 · D · $1,449,866 sold of $6,750,000 · 16 investors · min. $4,000 · role: Director EDGAR ↗

Raised $1.45M from 16 investors (100% of the $450K target) as of the latest filing. Michael is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Michael 26

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Smith

Director · 13 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Michael Litwack. Their page shows their other deals.

DT
No photo found yet (own website and image search run after this page is viewed)
Person

Dennis Templar

Executive Officer, Director · 13 shared filings (2 issuers)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

TZ
No photo found yet (own website and image search run after this page is viewed)
Person

Ted Ziemann

Director, Executive Officer · 13 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

WN
No photo found yet (own website and image search run after this page is viewed)
Person

William Nelson

Director · 11 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Michael Litwack. Their page shows their other deals.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Kali

Executive Officer · 11 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

EN
No photo found yet (own website and image search run after this page is viewed)
Person

Ed Neas

Director, Executive Officer · 11 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Handley

Executive Officer, Director · 10 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Ruud

Director · 10 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Roy Carver, Jr.

Director · 7 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Loretta Mealy

Director · 7 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Coder

Director · 7 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

DOUGLAS CODER

Director · 3 shared filings (2 issuers)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

TZ
No photo found yet (own website and image search run after this page is viewed)
Person

THEODORE ZIEMANN

Executive Officer, Director · 3 shared filings (2 issuers)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Doug Coder

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Smith, Ph.D.

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

WD
No photo found yet (own website and image search run after this page is viewed)
Person

William Nelson, MD. Ph.D.

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Coder

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

BRIAN MURPHY

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

BK
No photo found yet (own website and image search run after this page is viewed)
Person

BOB KALI

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

EN
No photo found yet (own website and image search run after this page is viewed)
Person

EDWIN NEAS

Director, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

TERRENCE MEALY

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

CS
No photo found yet (own website and image search run after this page is viewed)
Person

Cathy Sohn

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

CR
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Ruud

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

ED
No photo found yet (own website and image search run after this page is viewed)
Person

Ed Neas, Ph.D.

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

MV
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Voss

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

CR
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Rudd

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Litwack. Their page shows their other deals.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Michael Litwack by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Michael Litwack is listed on: none on file. No website or social profile named in Armis Biopharma, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #65,915 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Fort Collins, CO). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Colorado state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Colorado Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Michael Litwack appears on a new Form D, or when a court case or SEC action is matched to them. See plans →